sb 202190 has been researched along with Leukemia, Erythroblastic, Acute in 2 studies
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole: structure given in first source; inhibits p38 MAP kinase
Leukemia, Erythroblastic, Acute: A myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gasiorek, JJ | 1 |
| Mikhael, M | 1 |
| Garcia-Santos, D | 1 |
| Hui, ST | 1 |
| Ponka, P | 1 |
| Blank, V | 1 |
| Marone, M | 1 |
| Scambia, G | 1 |
| Bonanno, G | 1 |
| Rutella, S | 1 |
| de Ritis, D | 1 |
| Guidi, F | 1 |
| Leone, G | 1 |
| Pierelli, L | 1 |
2 other studies available for sb 202190 and Leukemia, Erythroblastic, Acute
| Article | Year |
|---|---|
Thioredoxin-interacting protein regulates the differentiation of murine erythroid precursors.
Topics: Animals; Anthracenes; Butadienes; Carrier Proteins; Cell Differentiation; Cell Line; Cell Line, Tumo | 2015 |
Transforming growth factor-beta1 transcriptionally activates CD34 and prevents induced differentiation of TF-1 cells in the absence of any cell-cycle effects.
Topics: Antigens, CD34; Cell Cycle; Cell Differentiation; Culture Media, Serum-Free; Cytokines; DNA-Binding | 2002 |